Literature DB >> 18282545

Allergic conjunctivitis.

Leonard Bielory1, Mitchell H Friedlaender.   

Abstract

Allergic conjunctivitis is common, especially during the allergy season. Consultation with the allergist to perform skin tests or in vitro tests may be useful and confirmatory in the diagnosis of ocular allergy. If treatment is necessary, antihistamines, mast cell stabilizers, and nonsteroidal anti-inflammatory drugs are safe and reasonably effective. Corticosteroids are an order of magnitude more potent than noncorticosteroids; however, they have attendant side effects that are best monitored by the ophthalmologist. The development of "modified" corticosteroids has been a boon to the treatment of ocular allergy because these drugs may reduce potential side effects without sacrificing potency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18282545     DOI: 10.1016/j.iac.2007.12.005

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  16 in total

1.  Prevalence and comorbidity of allergic diseases in preschool children.

Authors:  Hyeong Yun Kim; Eun Byul Kwon; Ji Hyeon Baek; Youn Ho Shin; Hye Yung Yum; Hye Mi Jee; Jung Won Yoon; Man Yong Han
Journal:  Korean J Pediatr       Date:  2013-08-27

2.  Eyelashes divert airflow to protect the eye.

Authors:  Guillermo J Amador; Wenbin Mao; Peter DeMercurio; Carmen Montero; Joel Clewis; Alexander Alexeev; David L Hu
Journal:  J R Soc Interface       Date:  2015-04-06       Impact factor: 4.118

3.  Allergic conjunctivitis and nasal allergy.

Authors:  Zdenek Pelikan
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

4.  Cellular changes in tears associated with keratoconjunctival responses induced by nasal allergy.

Authors:  Z Pelikan
Journal:  Eye (Lond)       Date:  2014-01-17       Impact factor: 3.775

5.  Intranasal corticosteroids: do they improve ocular allergy?

Authors:  Catherine Origlieri; Leonard Bielory
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

6.  Unlike Th1/Th17 cells, Th2/Th9 cells selectively migrate to the limbus/conjunctiva and initiate an eosinophilic infiltration process.

Authors:  Cuiyan Tan; Wambui S Wandu; Anthony St Leger; Jennifer Kielczewski; Eric F Wawrousek; Chi-Chao Chan; Igal Gery
Journal:  Exp Eye Res       Date:  2017-10-24       Impact factor: 3.467

7.  Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model.

Authors:  A Pauly; E Brasnu; L Riancho; F Brignole-Baudouin; C Baudouin
Journal:  Mol Vis       Date:  2011-03-16       Impact factor: 2.367

8.  Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis.

Authors:  Jeremy B Wingard; Francis S Mah
Journal:  Clin Ophthalmol       Date:  2011-02-15

9.  Comparative study of the ocular efficacy and safety of diclofenac sodium (0.1%) ophthalmic solution with that of ketorolac tromethamine (0.5%) ophthalmic solution in patients with acute seasonal allergic conjunctivitis.

Authors:  Navdeep Dehar; Anita Gupta; Gursatinder Singh
Journal:  Int J Appl Basic Med Res       Date:  2012-01

10.  Mediator profiles in tears during the conjunctival response induced by allergic reaction in the nasal mucosa.

Authors:  Zdenek Pelikan
Journal:  Mol Vis       Date:  2013-07-12       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.